|17.30||0||0.00||Vol 148.53K||1Y Perf 5.29%|
|Apr 19th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||21.40||Analyst Rating||Moderate Buy 2.20|
|Potential %||23.70||Finscreener Ranking||★★+ 48.05|
|Insiders Trans % 3/6/12 mo.||-100/-100/-94||Value Ranking||★★ 47.21|
|Insiders Value % 3/6/12 mo.||-100/-100/-99||Growth Ranking||★★★★ 59.48|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-99||Income Ranking||— -|
|Market Cap||825.04M||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||21.88||Earnings Date||6th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||6th May 2021|
|Estimated EPS Next Report||0.19|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||122.79K|
|Avg. Monthly Volume||141.11K|
|Avg. Quarterly Volume||191.59K|
Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) stock closed at 17.3 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 149.03K shares and market capitalization of 825.04M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 2027 people. Amphastar Pharmaceuticals Inc. CEO is Jack Yongfeng Zhang.
The one-year performance of Amphastar Pharmaceuticals Inc. stock is 5.29%, while year-to-date (YTD) performance is -13.97%. AMPH stock has a five-year performance of 33.9%. Its 52-week range is between 15.79 and 22.69, which gives AMPH stock a 52-week price range ratio of 21.88%
Amphastar Pharmaceuticals Inc. currently has a PE ratio of 668.10, a price-to-book (PB) ratio of 2.05, a price-to-sale (PS) ratio of 3.11, a price to cashflow ratio of 14.80, a PEG ratio of 2.32, a ROA of 0.22%, a ROC of 1.38% and a ROE of 0.34%. The company’s profit margin is -1.10%, its EBITDA margin is 10.90%, and its revenue ttm is $265.16 Million , which makes it $5.56 revenue per share.
Of the last four earnings reports from Amphastar Pharmaceuticals Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.19 for the next earnings report. Amphastar Pharmaceuticals Inc.’s next earnings report date is 06th May 2021.
The consensus rating of Wall Street analysts for Amphastar Pharmaceuticals Inc. is Moderate Buy (2.2), with a target price of $21.4, which is +23.70% compared to the current price. The earnings rating for Amphastar Pharmaceuticals Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Amphastar Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Amphastar Pharmaceuticals Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.06, ATR14 : 0.61, CCI20 : -122.23, Chaikin Money Flow : -0.15, MACD : -0.33, Money Flow Index : 43.63, ROC : -5.57, RSI : 50.22, STOCH (14,3) : 26.00, STOCH RSI : 0.21, UO : 38.32, Williams %R : -74.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Amphastar Pharmaceuticals Inc. in the last 12-months were: David Maris (Buy at a value of $40 520), Floyd F. Petersen (Option Excercise at a value of $1 443 972), Floyd F. Petersen (Sold 101 703 shares of value $1 858 474 ), Howard Lee (Option Excercise at a value of $1 443 972), Howard Lee (Sold 95 564 shares of value $1 764 188 ), Jack Yongfeng Zhang (Sold 200 000 shares of value $3 745 896 ), Jacob Liawatidewi (Option Excercise at a value of $580 076), Jacob Liawatidewi (Sold 67 138 shares of value $1 384 972 ), Michael A. Zasloff (Option Excercise at a value of $1 443 972), Michael A. Zasloff (Sold 95 564 shares of value $1 741 313 ), Richard Koo (Option Excercise at a value of $1 443 972), Richard Koo (Sold 95 564 shares of value $1 737 784 ), Richard Prins (Option Excercise at a value of $915 122), Richard Prins (Sold 72 564 shares of value $1 394 790 ), Rong Zhou (Option Excercise at a value of $228 200), Rong Zhou (Sold 22 969 shares of value $435 855 ), William J. Peters (Option Excercise at a value of $113 300), William J. Peters (Sold 29 907 shares of value $614 610 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.